267 results on '"Hohmann, Elizabeth L."'
Search Results
2. High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19)
3. In vivo expression of Salmonella enterica serotype Typhi genes in the blood of patients with typhoid fever in Bangladesh.
4. Analysis of Salmonella enterica serotype paratyphi A gene expression in the blood of bacteremic patients in Bangladesh.
5. Reply to Lagier et al
6. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Single-Center Experience
7. Nontyphoidal Salmonellosis
8. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection
9. Development and implementation of a clinical decision support system tool for the evaluation of suspected monkeypox infection
10. Development and implementation of a clinical decision support system tool for the evaluation of suspected monkeypox infection
11. Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
12. Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study
13. Universality of human microbial dynamics
14. Case 13-2022: A 56-Year-Old Man with Myalgias, Fever, and Bradycardia
15. Fecal Microbiota Transplant: Benefits and Risks
16. Killed but Metabolically Active Salmonella typhimurium: Application of a New Technology to an Old Vector
17. Faecal microbiota transplantation: more screening for old and new pathogens
18. Fecal Microbiota Transplantation for Clostridium difficile Infection—Reply
19. Macrophage-Inducible Expression of a Model Antigen in Salmonella typhimurium Enhances Immunogenicity
20. Innervation of Periosteum and Bone by Sympathetic Vasoactive Intestinal Peptide--Containing Nerve Fibers
21. sj-pdf-1-tai-10.1177_20499361211046669 – Supplemental material for Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period
22. Case 25-2014: A Man with Ulcerative Colitis and Bloody Diarrhea
23. Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection
24. Local Peritoneal Irrigation with Intestinal Alkaline Phosphatase Is Protective Against Peritonitis in Mice
25. A Role for Intestinal Alkaline Phosphatase in the Maintenance of Local Gut Immunity
26. phoP/phoQ-Deleted Salmonella typhi (Ty800) Is a Safe and Immunogenic Single-Dose Typhoid Fever Vaccine in Volunteers
27. Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase
28. Case 25-2014: A 37-Year-Old Man with Ulcerative Colitis and Bloody Diarrhea
29. Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period
30. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system
31. Case 8-2012: A 53-Year-Old Man with Crohnʼs Disease, Diarrhea, Fever, and Bacteremia
32. Attenuated Listeria monocytogenes vaccine vectors expressing Influenza A nucleoprotein: preclinical evaluation and oral inoculation of volunteers
33. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial
34. OR26-06 Fecal Microbiota Transplantation Trial for the Improvement of Metabolism (FMT-TRIM): A Randomized Double-Blind Placebo-Controlled Pilot Trial
35. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
36. Regulation of host immune responses by modification of Salmonella virulence genes
37. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
38. Gene Therapy — Still a Work in Clinical and Regulatory Progress
39. Transcriptional regulation of Salmonella virulence: a PhoQ periplasmic domain mutation results in increased net phosphotransfer to PhoP
40. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
41. Listeriosis during pregnancy: a case series and review of 222 cases
42. 622 – Double-Blind Randomized Placebo-Controlled Trial of Weekly Fecal Microbiota Transplantation (FMT) Capsules in Obese Adults: Evaluating Microbiota Engraftment and Improvements in Insulin Sensitivity
43. Recurrent Relatively Resistant Salmonella infantis Infection in 2 Immunocompromised Hosts Cleared With Prolonged Antibiotics and Fecal Microbiota Transplantation
44. Central nervous system infection with Listeria monocytogenes: 33 years' experience at a general hospital and review of 776 episodes from the literature
45. Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation
46. Safety and immunogenicity of phoP/ phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers
47. Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients
48. On the Stability Landscape of the Human Gut Microbiome: Implications for Microbiome-based Therapies
49. Ovarian Endometrioma Superinfected With Salmonella: Case Report and Review of the Literature
50. Reply to Lagier et al
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.